Welcome to LookChem.com Sign In|Join Free

CAS

  • or
8-CHLORO-4-HYDROXYQUINOLINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

57797-97-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 57797-97-4 Structure
  • Basic information

    1. Product Name: 8-CHLORO-4-HYDROXYQUINOLINE
    2. Synonyms: 8-CHLORO-4-HYDROXYQUINOLINE;8-CHLORO-4-QUINOLINOL;4-HYDROXY-8-CHLOROQUINOLINE;4-Chloro-4-hydroxyquinoline;8-Chloroquinolin-4-ol
    3. CAS NO:57797-97-4
    4. Molecular Formula: C9H6ClNO
    5. Molecular Weight: 179.6
    6. EINECS: -0
    7. Product Categories: N/A
    8. Mol File: 57797-97-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 300.8°Cat760mmHg
    3. Flash Point: 135.7°C
    4. Appearance: /
    5. Density: 1.339g/cm3
    6. Vapor Pressure: 0.00109mmHg at 25°C
    7. Refractive Index: 1.608
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 8-CHLORO-4-HYDROXYQUINOLINE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 8-CHLORO-4-HYDROXYQUINOLINE(57797-97-4)
    12. EPA Substance Registry System: 8-CHLORO-4-HYDROXYQUINOLINE(57797-97-4)
  • Safety Data

    1. Hazard Codes: T
    2. Statements: 25-41
    3. Safety Statements: 26-39-45
    4. RIDADR: UN 2811 6.1 / PGIII
    5. WGK Germany: 3
    6. RTECS:
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 57797-97-4(Hazardous Substances Data)

57797-97-4 Usage

Chemical Properties

Off White powder

Check Digit Verification of cas no

The CAS Registry Mumber 57797-97-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,7,9 and 7 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 57797-97:
(7*5)+(6*7)+(5*7)+(4*9)+(3*7)+(2*9)+(1*7)=194
194 % 10 = 4
So 57797-97-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H6ClNO/c10-7-3-1-2-6-8(12)4-5-11-9(6)7/h1-5H,(H,11,12)

57797-97-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (BBO000039)  8-Chloro-4-hydroxyquinoline  AldrichCPR

  • 57797-97-4

  • BBO000039-1G

  • 2,255.76CNY

  • Detail

57797-97-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 8-chloro-1H-quinolin-4-one

1.2 Other means of identification

Product number -
Other names 8-chlorohydroquinolin-4-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:57797-97-4 SDS

57797-97-4Downstream Products

57797-97-4Relevant articles and documents

A one-pot, two-step synthesis of 3-deazacanthin-4-ones via sequential Pd-catalyzed Suzuki-Miyaura and Cu-catalyzed Buchwald-Hartwig reactions

Broumidis, Emmanouil,Koutentis, Panayiotis A.

, p. 2661 - 2664 (2017/06/14)

3-Deazacanthin-4-one and nine analogues, including the 8-aza analogue, were prepared rapidly and in high yields from 8-iodoquinolones and 2-chloro(het)arylboronic acids. The strategy involves construction of the central B ring via concomitant Pd-catalyzed

A novel ionic liquid mediated synthesis of 4(1H)-quinolones, 5H-thiazolo[3,2-a]pyrimidin-5-one and 4H-pyrimido[2,1-b]benzothiazol-4-ones

Yadav, Ashok K.,Sharma, Gopi Ram,Dhakad, Pankaj,Yadav, Tripti

experimental part, p. 859 - 862 (2012/03/08)

A new, convenient, environmentally benign two-step synthesis of 4(1H)-quinolones, 5H-thiazolo[3,2-a]pyrimidin-5-one and 4H-pyrimido[2,1-b] benzothiazol-4-ones have been developed by first condensing substituted arylamine/2-aminothiazole/2-aminobenzenethia

HEPATITIS C INHIBITOR DIPEPTIDE ANALOGS

-

Page/Page column 68, (2008/06/13)

The present invention relates to compounds of formula (I): wherein R1, R2, R4, n and m are as defined herein and R3 is selected from: (i) -C(O)OR31 wherein R31 is (C1-6)alkyl or aryl, wherein the (C1-6)alkyl is optionally substituted with one to three halogen substituents; (ii) -C(O)NR32R33, wherein R32 and R33 are each independently selected form H, (C1-6)alkyl, and Het; (iii) -SOvR34, wherein v is 1 or 2 and R34 is selected from: (C1-6)alkyl, aryl, Het, and NR32R33 wherein R32 and R33 are as defined above; and (iv) -CO(O)-R35, wherein R35 is selected from (C1-8)alkyl, (C3-7)cycloalkyl-(C1-4)alkyl, aryl, aryl-(C1-6)alkyl, Het and Het-(C1-6)alkyl, each of which are optionally substituted with one or more substituents each independently selected from halo, (C1-6)alkyl, (C3-7)cycloalkyl, aryl, Het, hydroxyl, -O-(C1-6)alkyl, -S-(C1-6)alkyl, -SO-(C1-6)alkyl, -SO2-(C1-6)alkyl, -O-aryl, -S-aryl, -SO-aryl and -SO2-aryl, wherein the aryl portion of the -O-aryl, -S-aryl, -SO-aryl and -SO2-aryl are each optionally substituted with one to five halo substituents. The present invention further relates to pharmaceutical compositions containing the compounds of formula (I) and methods for using these analogs in the treatment of HCV infection.

Hepatitis C inhibitor peptide analogs

-

Page/Page column 27-28, (2010/02/15)

Compounds of formula (I): wherein R1, R2, R3, R4, R5, Y, n and m are as defined herein. The compounds are useful as inhibitors of HCV NS3 protease.

HEPATITIS C INHIBITOR PEPTIDE ANALOGS

-

Page/Page column 81-82, (2010/02/15)

The invention relates to compounds of formula (I) wherein R', R2, R3, R4, R5, R6, Y, n and m are as defined herein. The compounds are useful for the treatment and prevention of hepatitis C viral infections in mammals by inhibiting HCV NS3 protease. The invention further relates to azalactone compounds of the formula (III) which can be reacted with an amide anion to produce the compounds of formula (I).

Synthesis of ring-substituted 4-aminoquinolines and evaluation of their antimalarial activities

Madrid, Peter B.,Sherrill, John,Liou, Ally P.,Weisman, Jennifer L.,DeRisi, Joseph L.,Guy, R. Kiplin

, p. 1015 - 1018 (2007/10/03)

A simple two-step synthesis method was used to make 51 B-ring-substituted 4-hydroxyquinolines allowing analysis of the effect of ring substitutions on inhibition of growth of chloroquine sensitive and resistant strains of Plasmodium falciparum, the dominant cause of malaria morbidity. Substituted quinoline rings other than the 7-chloroquinoline ring found in chloroquine were found to have significant activity against the drug-resistant strain of P. falciparum W2.

Synthesis of n-chloroquinolines and n-ethynylquinolines (n=2, 4, 8): Homo and heterocoupling reactions

Rodríguez, J. Gonzalo,De Los Rios, Cristobal,Lafuente, Antonio

, p. 9042 - 9051 (2007/10/03)

The n-(ethynyl)quinolines were satisfactorily prepared by heterocoupling reaction between the appropriate n-chloroquinoline and 2-methyl-3-butyn-2-ol, catalyzed by palladium, followed by treatment with a catalytic amount of powdered sodium hydroxide in toluene. The n-(ethynyl)quinolines were transformed in the corresponding conjugate 1,4-bis[n′-(quinolyl)]buta-1,3-diynes by oxidative dimerization, catalyzed by cuprous chloride, with excellent yields. Moreover, the heterocoupling between n′-haloquinoline and n′-(ethynyl)quinoline (n′, 2′ or 3′), catalyzed by palladium, gives 2′,2′-bis(quinoline) or 1,2-di(3′-quinolyl) ethyne, respectively. The same coupling reaction with zerovalent nickel complexes, gives a mixture of 1,2,4- and 1,3,5-tri(n′-quinolyl)benzene.

Antimalarials: Synthesis of 4-aminoquinolines that circumvent drug resistance in malaria parasites

De,Byers,Krogstad

, p. 315 - 320 (2007/10/03)

The strategies described here have permitted the synthesis of a series of 4-aminoquinoline antimalarials. Substantive improvements over previous syntheses include nucleophilic substitution with neat amine rather than in phenol, regioselective reductive alkylation to convert the terminal primary amine (12a-20a) on the diaminoalkane side chain to a diethylamino group, and purification by column chromatography with basic alumina. The 1H nmr spectra obtained after regioselective reductive alkylation with sodium borodeuteride (in comparison with sodium borohydride) demonstrated that this reductive alkylation proceeds via formation and subsequent reduction of the corresponding diamides in situ.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 57797-97-4